Here are what the editors at HealthDay consider to be the most important developments in Urology for November 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
FDA to Update Medical Device Approvals Process
TUESDAY, Nov. 27, 2018 (HealthDay News) — A major update of the United States’ system for approving medical devices was announced yesterday by the Food and Drug Administration.
CBS/AP News Article
More Information
Men Should Avoid ‘Rhino’ Sexual Enhancement Products, FDA Says
TUESDAY, Nov. 27, 2018 (HealthDay News) — The U.S. Food and Drug Administration is warning men that “Rhino” products promising better sex may pose serious health risks.
Four Principles Underlie Patient and Family Partnership in Care
TUESDAY, Nov. 27, 2018 (HealthDay News) — Patient and family partnership in care should include treatment of patients and families with dignity and respect, their active engagement in all aspects of care, and their contribution to the improvement of health care systems and education of health care professionals, according to a position paper published online Nov. 27 in the Annals of Internal Medicine.
Position Paper
Editorial (subscription or payment may be required)
ACA Coverage Substantial, but Did Not Impact Labor Markets
MONDAY, Nov. 26, 2018 (HealthDay News) — Millions of workers gained insurance coverage under the Affordable Care Act (ACA) without adverse effects on labor markets, according to a report published by the Robert Wood Johnson Foundation and the Urban Institute.
Report: How Have Workers Fared Under the ACA?
CDC: 8.8 Percent Uninsured in U.S. in First Half of 2018
FRIDAY, Nov. 16, 2018 (HealthDay News) — In the first six months of 2018, 8.8 percent of U.S. individuals of all ages were uninsured, which was not significantly different from 2017, according to a report published Nov. 15 by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
Name-Brand Medications Driving Spike in U.S. Drug Spending
THURSDAY, Nov. 15, 2018 (HealthDay News) — Rising drug spending in the United States is being fueled by expensive name-brand prescription medicines, a new study shows.
NBC News Article
Blue Cross Blue Shield Report
Patient Experiences Shed Light on Diagnostic Errors
THURSDAY, Nov. 15, 2018 (HealthDay News) — Data from patient- and family-reported error narratives indicate that problems related to patient-physician interactions are major contributors to diagnostic errors, according to a study published in the November issue of Health Affairs.
Abstract/Full Text (subscription or payment may be required)
AMA to Collect Data on Suicide Among Doctors-in-Training
.jpg)
Tadalafil Linked to Glaucoma in Men With Lower Urinary Tract Symptoms 
Platelet-Rich Plasma, Shockwave Therapy Show Therapeutic Efficacy in Interstitial Cystitis 
About One-Third of Men Continuously Using Tamsulosin See Minimal to No Effect 
Remote Access to Urinary Incontinence Treatments Aids Women Veterans 
App Can Help Reduce Interdialytic Weight Gain in Chronic Hemodialysis 
Organized Sports-Based Interventions Can Improve Gross Motor Skills in Autism 
Smartphone-Based Self-Screening Can ID Ocular Surface Malignancies 
Smartphone Apps, Wearables Boost Activity in People With Cardiovascular Disease 
